Arnold Lippa

Company: RespireRx Pharmaceuticals Inc

Job title: Exec. Chairman, Chief Executive Officer and Chief Scientific Officer

Seminars:

Pharmaceutical Cannabinoids: A Company Update 12:00 pm

Examine re-purposing dronabinol for the treatment of obstructive sleep apnea (OSA) and other indications Explore completion of two successful phase 2 clinical trials in OSA Develop lipid nanoparticle formulation to overcome current dronabinol limitationsRead more

day: Day One Track B - morning